CASTLE BIOSCIENCES INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Castle Biosciences Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
  • Castle Biosciences Inc Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $11.9M, a 2.51% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $11.9M +$291K +2.51% Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $11.6M +$82K +0.71% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $12M +$560K +4.91% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $12.3M +$125K +1.03% Dec 31, 2023 10-Q 2024-11-04
Q3 2023 $11.6M -$991K -7.86% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $11.5M +$4.54M +64.7% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $11.4M +$4.18M +57.9% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $12.2M +$4.8M +65% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $12.6M +$12.6M Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $7M +$7M Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $7.22M +$7.22M Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $7.38M +$7.38M Dec 31, 2021 10-K 2023-02-28
Q3 2021 $0 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $0 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $0 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $0 Dec 31, 2020 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.